Holdings
Patient Square Capital LP
As of Jun 30, 2026, Patient Square Capital LP reported 20 positions worth US$593M. Largest: Roivant Sciences Ltd., Revolution Medicines, Inc. and Mirum Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Roivant Sciences Ltd. | 8.02M | US$284M | −145K | Jun 30, 2026 |
| Revolution Medicines, Inc. | 276K | US$51.7M | new | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 261K | US$30.5M | +30,500 | Jun 30, 2026 |
| Abivax Sa | 207K | US$27.5M | +85,255 | Jun 30, 2026 |
| Beone Medicines Ltd. Class A | 90,020 | US$25.7M | +9,478 | Jun 30, 2026 |
| Argenx Se | 23,000 | US$21.3M | −13,718 | Jun 30, 2026 |
| United Therapeutics Corporation | 37,120 | US$20.1M | new | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 425K | US$16.4M | −171K | Jun 30, 2026 |
| Dbv Technologies Sa | 909K | US$14.9M | +216K | Jun 30, 2026 |
| Xenon Pharmaceuticals Inc. | 220K | US$13.3M | −7,000 | Jun 30, 2026 |